NAD+ IV Therapy Vancouver: What It Costs, What the Science Says, and Where to Get It (2026)
Quick Answer
NAD+ IV therapy in Vancouver typically costs between $300 and $600 per session, with most clinics recommending an initial series of 4 to 10 treatments. Sessions generally last 2 to 4 hours, and the therapy is not covered by MSP or most extended health insurance plans. While early research shows promise for cellular energy and cognitive function, large-scale human clinical trials remain limited. Consult a licensed BC physician before starting NAD+ IV therapy, and use the BCMedicalAccess.ca directory to find qualified providers in your area.
Last Updated: May 26, 2026 By: BCMedicalAccess Editorial Team
What Is NAD+ and Why Does It Matter?
Nicotinamide adenine dinucleotide, commonly known as NAD+, is a coenzyme found in every living cell of your body. It plays a fundamental role in hundreds of metabolic processes, making it one of the most important molecules for maintaining cellular health and energy production.
At its core, NAD+ functions as an electron carrier in your mitochondria, the powerhouses of your cells. When you eat food, your body converts those nutrients into usable energy through a process called cellular respiration. NAD+ is essential for this conversion, shuttling electrons between molecules and enabling the production of adenosine triphosphate (ATP), which is the primary energy currency your cells use for virtually every function.
Beyond energy production, NAD+ serves as a critical substrate for several enzyme families that regulate cellular health:
Sirtuins are a family of proteins often called "longevity genes." These enzymes require NAD+ to function and are involved in DNA repair, inflammation regulation, and metabolic efficiency. Research published in Cell Metabolism has shown that sirtuin activity is directly dependent on NAD+ availability, meaning low NAD+ levels can impair your body's ability to repair cellular damage.
PARPs (Poly ADP-ribose polymerases) are enzymes responsible for DNA repair. When your DNA sustains damage from oxidative stress, UV exposure, or other environmental factors, PARPs consume NAD+ to facilitate repairs. This creates a challenging dynamic: the more DNA damage you accumulate, the more NAD+ your body uses, potentially depleting reserves needed for other critical functions.
CD38 is an enzyme that increases with age and chronic inflammation. Unfortunately, CD38 also consumes NAD+, and research from the Buck Institute for Research on Aging has demonstrated that rising CD38 levels contribute significantly to age-related NAD+ decline.
Here is where the science becomes personally relevant: NAD+ levels decline substantially as we age. Studies indicate that by age 50, most people have approximately half the NAD+ levels they had at age 20. By age 80, levels may drop to 1-10% of youthful concentrations. This decline correlates with many hallmarks of aging, including reduced energy, cognitive changes, slower recovery from exercise or illness, and increased susceptibility to age-related diseases.
This natural decline has sparked significant interest in NAD+ restoration therapies. The theory is straightforward: if declining NAD+ contributes to aging and cellular dysfunction, restoring NAD+ levels might support healthier cellular function. This premise underlies the growing popularity of NAD+ IV therapy in Vancouver and across Canada.
The Science Behind NAD+ Therapy: What Is Proven vs What Is Promising
When evaluating NAD+ therapy, it is essential to distinguish between well-established science, promising preliminary research, and marketing claims that outpace the evidence. Here is an honest assessment of where the research stands as of 2026.
What Is Well-Established
The fundamental biochemistry of NAD+ is not controversial. Decades of peer-reviewed research confirm that NAD+ is essential for cellular energy production, DNA repair mechanisms, and the function of sirtuins and other longevity-associated enzymes. The age-related decline in NAD+ levels is also well-documented across multiple studies and populations.
Research has also established that NAD+ precursors (compounds the body converts into NAD+) can effectively raise NAD+ levels in humans. A 2022 study published in Nature Communications demonstrated that nicotinamide riboside (NR) supplementation increased blood NAD+ levels by up to 60% in healthy adults. Similar results have been observed with nicotinamide mononucleotide (NMN).
What Is Promising but Still Under Investigation
Several areas of NAD+ research show genuine promise but require additional human trials before definitive conclusions can be drawn:
Cognitive function: Animal studies have consistently shown that boosting NAD+ levels improves cognitive performance and offers neuroprotective effects. A 2023 clinical trial published in Alzheimer's Research & Therapy found that NAD+ precursor supplementation improved certain cognitive markers in older adults with mild cognitive impairment. However, larger trials are needed to confirm these findings and determine optimal protocols.
Metabolic health: Research from the University of Colorado demonstrated that NR supplementation reduced blood pressure and arterial stiffness in healthy middle-aged and older adults. Studies in mice have shown improvements in insulin sensitivity and metabolic function with NAD+ boosting. Human trials are ongoing to determine whether these benefits translate consistently to clinical outcomes.
Physical performance and recovery: Some studies suggest NAD+ restoration may improve exercise capacity and recovery times, particularly in older adults. A 2024 study in Sports Medicine found that NAD+ precursor supplementation enhanced muscle recovery markers in athletes over 40.
Frequently Asked Questions
How much does NAD+ IV therapy cost in Vancouver?
NAD+ IV therapy in Vancouver typically ranges from $300 to $600 per session. Most clinics recommend an initial series of 4 to 10 sessions, which can bring the total cost for a full treatment protocol to between $1,200 and $6,000. Prices vary based on the dosage administered and the clinic's location and amenities.
Is NAD+ IV therapy covered by MSP or extended health insurance in BC?
No, NAD+ IV therapy is not covered by the BC Medical Services Plan (MSP) or most extended health insurance plans. This treatment is considered elective and is not approved by Health Canada for treating any specific medical condition. Patients should expect to pay out of pocket for all sessions.
How long does a NAD+ IV therapy session take?
A typical NAD+ IV therapy session in Vancouver takes between 2 and 4 hours to complete. The infusion must be administered slowly to minimize potential side effects such as nausea, flushing, or chest tightness. Some clinics offer lower-dose "express" sessions that may take less time.
What are the potential side effects of NAD+ IV therapy?
Common side effects during NAD+ IV infusion include nausea, flushing, lightheadedness, and chest or abdominal discomfort. These effects are typically related to infusion speed and often resolve when the drip rate is slowed. Serious adverse events are rare but possible, which is why treatment should always be supervised by qualified medical professionals.
Is NAD+ IV therapy approved by Health Canada?
NAD+ IV therapy is not approved by Health Canada as a treatment for any disease or medical condition. While the compound itself is not prohibited, clinics offering this therapy do so as an elective wellness service. Patients should discuss the risks and potential benefits with a licensed BC physician before proceeding.
How many NAD+ IV therapy sessions are typically recommended?
Most Vancouver clinics recommend an initial protocol of 4 to 10 NAD+ IV sessions, often administered over consecutive days or within a 2-week period. After the initial series, maintenance sessions may be suggested monthly or quarterly. The optimal protocol has not been established through large-scale clinical trials, so recommendations vary between providers.
What is the difference between NAD+ IV therapy and oral NAD+ supplements?
NAD+ IV therapy delivers the coenzyme directly into the bloodstream, bypassing the digestive system and potentially achieving higher cellular concentrations more quickly. Oral supplements typically contain NAD+ precursors such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), which the body must convert into NAD+. IV therapy is significantly more expensive but may offer faster results for some individuals.
Who should not receive NAD+ IV therapy?
Individuals who are pregnant or breastfeeding, those with certain cardiovascular conditions, and people taking specific medications should consult a physician before considering NAD+ IV therapy. A thorough medical history review is essential before treatment. Always disclose all health conditions and medications to your healthcare provider before starting any IV therapy.
Health Disclaimer: This article is for informational purposes only and does not constitute medical advice. NAD+ IV therapy is not approved by Health Canada as a treatment for any disease. Always consult a qualified healthcare professional for diagnosis and treatment. For health information and advice, call HealthLinkBC at 8-1-1.